Pierre H Chambon

This inventor holds 28 USPTO granted patents and 3 published patent applications and 3 EPO patents, primarily in Nuclear Receptor Biology. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Université Louis Pasteur. Active years: 1993-2021.

USPTO Granted Patents = 28 (Patent Applications = 3)

% Patents Active = 96.4

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 335(Granted Patents)

Location History:

Strasbourg, FR (1994)
67085 Strasbourg, FR (1995)
Bleasheim, FR (1996)
Blaesheim, FR (1993 - 2021)

Company Filing History:

11 out of 5,383

Centre National De La Recherche Scientifique

patents

8 out of 1,853

National Institute of Health and Medical Research

patents

6 out of 32

Université Louis Pasteur

patents

4. 5 out of 3,737

Bristol-Myers Squibb Compnay

patents

5. 3 out of 1,624

E. R. Squibb Sons, Inc.

Association Pour La Recherche a L'igbmc (Ari)

patent

10. 1 out of 1

Association Pour Le Development De La Recherche En Genetique Moleculaire (Aderegem)

patent

11. 1 out of 1

Gie-Cerbm, Centre Europeen De Recherche En Biologie Et En Medecine (Gie)

patent

12. 1 out of 1

Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie)

patent

13. 1 out of 1

Universite Louis Pasteur Strasbourg

patent

14. 1 out of 2

Université Louis Pasteur Strasbourg I

patents

15. 1 out of 186

Universitéde Strasbourg

patents

16. 1 out of 2,424

University of Illinois

patents

17. 6 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2021

Loading Chart...

Areas of Expertise:

Glucocorticoid Receptor

Transgenic Mouse

Retinoic Acid Receptor

Pharmaceutical Composition

Gene Expression

Biological Activity

Protein Preparation

Antibodies

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11179363 - Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) and uses thereof (2021-11-23),

2. 9273115 - Method for controlling the biological activity of a protein in a vertebrate cell (2016-03-01),

3. 7112715 - Transgenic mouse for targeted recombination mediated by modified Cre-ER (2006-09-26),

4. 7074611 - Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof (2006-07-11),

5. 6861508 - Transcriptional intermediary factor-2 (2005-03-01),

6. 6699686 - Modified nuclear glucocorticoid receptor, fusion protein, and DNA fragments coding for said receptor and said fusion protein (2004-03-02),

7. 6653322 - Therapeutic combinations of RAR antagonists and RXR agonists and use thereof (2003-11-25),

8. 6635429 - Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof (2003-10-21),

9. 6521814 - Use of ligands for treatment of diseases responsive to retinoids (2003-02-18),

10. 6486381 - Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins (2002-11-26),

11. 6444438 - Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains (2002-09-03),

12. 6328956 - Pharmaceutical composition for the treatment or prevention of a malignant tumor (2001-12-11),

13. 6268173 - Polynucleotide encoding transcriptional intermediary factor-2 (2001-07-31),

14. 6203795 - Pharmaceutical composition for the treatment or prevention of a malignant tumor (2001-03-20),

15. 6130230 - Therapeutic combinations of RAR antagonists and RXR agonists and use (2000-10-10),

Title: The Innovative Journey of Inventor Pierre H Chambon

Introduction: Pierre H Chambon, a distinguished male inventor hailing from Blaesheim, France, has made significant contributions to the field of innovations and inventions.

Latest Patents: Pierre H Chambon holds several patents in the areas of biotechnology and molecular biology, showcasing his expertise and creativity in these fields.

Career Highlights: Throughout his illustrious career, Pierre H Chambon has been a trailblazer in the scientific community, pioneering groundbreaking research and inventions that have had a lasting impact on the industry.

Collaborations: Pierre H Chambon has collaborated with leading researchers, scientists, and institutions around the world, fostering a culture of innovation and knowledge-sharing in his field.

Conclusion: In conclusion, Pierre H Chambon's dedication to innovation and his remarkable contributions to the world of inventions have solidified his legacy as a visionary inventor in the realm of biotechnology and molecular biology.